About Index Trending news
Analyze
Pricing
Seres Therapeutics

Seres Therapeutics

Work at Seres Therapeutics? Add yourself to this profile

Seres Therapeutics

SERES HEALTH designs and develops products that will improve the dignity for patients with stomas & ostomies
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co nuTonomy nuTonomy HubSpot HubSpot Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
25 Jun 2015
$134,000,000
IPO
Flagship Ventures, Fidelity, Enso Ventures, +1
Added by

Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO

Xconomy
06 Jan 2015
$65,000,000
Venture capital (Series D)
Nestlé Health Science

Seres Health Announces $65 Million Investment from Nestle Health Science

prnewswire
02 Dec 2014
$48,000,000
Venture capital (Series C)
Flagship Ventures
09 Jun 2014
$10,000,000
Venture capital (Series B)
Flagship Ventures, Alexandria Venture, Enso Ventures, +1
21 Nov 2013
$10,500,000
Venture capital (Series A)
Flagship Ventures, Enso Ventures